Annual Current Assets
$243.69 M
-$110.29 M-31.16%
December 31, 2023
Summary
- As of February 7, 2025, RPTX annual total current assets is $243.69 million, with the most recent change of -$110.29 million (-31.16%) on December 31, 2023.
- During the last 3 years, RPTX annual current assets has fallen by -$102.86 million (-29.68%).
- RPTX annual current assets is now -31.16% below its all-time high of $353.98 million, reached on December 31, 2022.
Performance
RPTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$200.40 M
-$28.14 M-12.31%
September 30, 2024
Summary
- As of February 7, 2025, RPTX quarterly total current assets is $200.40 million, with the most recent change of -$28.14 million (-12.31%) on September 30, 2024.
- Over the past year, RPTX quarterly current assets has dropped by -$74.69 million (-27.15%).
- RPTX quarterly current assets is now -48.69% below its all-time high of $390.60 million, reached on September 30, 2022.
Performance
RPTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
RPTX Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -31.2% | -27.1% |
3 y3 years | -29.7% | -28.5% |
5 y5 years | +1922.6% | - |
RPTX Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -31.2% | at low | -48.7% | at low |
5 y | 5-year | -31.2% | +147.2% | -48.7% | +128.0% |
alltime | all time | -31.2% | +1922.6% | -48.7% | +128.0% |
Repare Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $200.40 M(-12.3%) |
Jun 2024 | - | $228.54 M(-10.3%) |
Mar 2024 | - | $254.67 M(+4.5%) |
Dec 2023 | $10.21 M(+1.2%) | $243.69 M(-11.4%) |
Sep 2023 | - | $275.09 M(-5.8%) |
Jun 2023 | - | $291.93 M(-10.3%) |
Mar 2023 | - | $325.53 M(-8.0%) |
Dec 2022 | $10.10 M | $353.98 M(-9.4%) |
Sep 2022 | - | $390.60 M(+34.8%) |
Jun 2022 | - | $289.74 M(-9.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $319.23 M(-9.2%) |
Dec 2021 | $17.30 M(+64.2%) | $351.41 M(+25.3%) |
Sep 2021 | - | $280.38 M(-9.3%) |
Jun 2021 | - | $309.19 M(-5.8%) |
Mar 2021 | - | $328.21 M(-5.3%) |
Dec 2020 | $10.53 M(+155.5%) | $346.55 M(-4.1%) |
Sep 2020 | - | $361.26 M(-4.2%) |
Jun 2020 | - | $377.26 M(+329.3%) |
Mar 2020 | - | $87.89 M(-10.8%) |
Dec 2019 | $4.12 M(+119.7%) | $98.57 M |
Dec 2018 | $1.88 M | - |
FAQ
- What is Repare Therapeutics annual total current assets?
- What is the all time high annual current assets for Repare Therapeutics?
- What is Repare Therapeutics annual current assets year-on-year change?
- What is Repare Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Repare Therapeutics?
- What is Repare Therapeutics quarterly current assets year-on-year change?
What is Repare Therapeutics annual total current assets?
The current annual current assets of RPTX is $243.69 M
What is the all time high annual current assets for Repare Therapeutics?
Repare Therapeutics all-time high annual total current assets is $353.98 M
What is Repare Therapeutics annual current assets year-on-year change?
Over the past year, RPTX annual total current assets has changed by -$110.29 M (-31.16%)
What is Repare Therapeutics quarterly total current assets?
The current quarterly current assets of RPTX is $200.40 M
What is the all time high quarterly current assets for Repare Therapeutics?
Repare Therapeutics all-time high quarterly total current assets is $390.60 M
What is Repare Therapeutics quarterly current assets year-on-year change?
Over the past year, RPTX quarterly total current assets has changed by -$74.69 M (-27.15%)